NGM Biopharmaceuticals (NGM) PT Raised to $30 at Cowen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to NGM Biopharmaceuticals (NGM) PT Raised to $30 at Cowen

NGM Biopharmaceuticals (NGM) to Resume Trading at 8:30 am

February 24, 2020 8:26 AM EST

NGM Biopharmaceuticals (NASDAQ: NGM) to Resume Trading at 8:30 am

... More

NGM Biopharmaceuticals (NGM) Phase 2 Study of Aldafermin in NASH Patients Shows Statistically Significant Achievement of Composite Endpoint

February 24, 2020 8:09 AM EST

Clinically meaningful response rates of 38% of patients treated with aldafermin having liver fibrosis improvement of 1 stage and 24% of patients achieving resolution of NASH at 24 weeks--

--22% of aldafermin-treated patients versus 0% placebo achieved composite endpoint of both fibrosis improvement and resolution of NASH, a statistically significant result--

--Data support aldafermins differentiation in the NASH development landscape as a potential potent monotherapy that rapidly improves and sustains liver health with a favorable tolerability profile--

--Company to host conference call and webcast today at 8:30 a.m. ET (5:30 a.m.... More